Log in to save to my catalogue

Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in...

Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5884797

Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma

About this item

Full title

Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma

Publisher

China: Springer Nature B.V

Journal title

Bone research, 2018-04, Vol.6, p.11-7

Language

English

Formats

Publication information

Publisher

China: Springer Nature B.V

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Osteosarcoma is the most common primary bone sarcoma that mostly occurs in young adults. The causes of osteosarcoma are heterogeneous and still not fully understood. Identification of novel, important oncogenic factors in osteosarcoma and development of better, effective therapeutic approaches are in urgent need for better treatment of osteosarcoma...

Alternative Titles

Full title

Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5884797

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5884797

Other Identifiers

ISSN

2095-4700

E-ISSN

2095-6231

DOI

10.1038/s41413-018-0009-8

How to access this item